Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

actisomide

Known as: 4-(2-(bis(1-methylethyl)amino)ethyl)-4,4a,5,6,7,8-hexahydro-1-methyl-4-phenyl-3H-pyrido(1,2-c)pyrimidin-3-one 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
SummaryThe metabolism of actisomide, a novel antiarrhythmic agent, was studied in the dog, monkey and man and was found to be… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2004
2004
The pharmacokinetics of a novel antiarrhythmic drug, actisomide, were examined in the rat, dog, monkey, and human. The terminal… Expand
Highly Cited
1999
Highly Cited
1999
  • I. Mahmood
  • The Journal of pharmacy and pharmacology
  • 1999
  • Corpus ID: 20717873
Pharmacokinetic parameters (clearance, CL, volume of distribution in the central compartment, VdC, and elimination half‐life, t… Expand
1991
1991
The pharmacokinetics and tolerance of actisomide (SC-36602) were determined following intravenous doses of 2.1, 4.2, and 8.4 mg… Expand
  • table 1
  • figure I
  • table 2
  • table 3